541 related articles for article (PubMed ID: 8278696)
1. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
[TBL] [Abstract][Full Text] [Related]
2. [Effects of pharmacological doses of polyunsaturated fatty acids of the series 3 on the concentration of plasma lipoproteins].
García Osle M; Mourente G; Mangas A; Santi MJ; Baraibar E; García Calzado MC; Lorenzo A; Barba A; Millán J
An Med Interna; 1994 Oct; 11(10):473-8. PubMed ID: 7865652
[TBL] [Abstract][Full Text] [Related]
3. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
4. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
5. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
Castro IA; Monteiro VC; Barroso LP; Bertolami MC
Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
[TBL] [Abstract][Full Text] [Related]
6. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
Singer P; Hüve J
Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia.
Bunea R; El Farrah K; Deutsch L
Altern Med Rev; 2004 Dec; 9(4):420-8. PubMed ID: 15656713
[TBL] [Abstract][Full Text] [Related]
8. [The effect of diets containing omega-3 polyunsaturated fatty acids on biochemical indicators and the fatty acid composition of the cell membranes in patients with ischemic heart disease and hereditary hyperlipidemia].
Samsonov MA; Levachev MM; Pogozheva AV; Korf II; Abbakumov AS
Vopr Med Khim; 1992; 38(3):22-4. PubMed ID: 1413642
[TBL] [Abstract][Full Text] [Related]
9. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
10. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
Haacke H; Parwaresch MR; Mäder C
Dtsch Med Wochenschr; 1976 Sep; 101(39):1413-7. PubMed ID: 185036
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
Berrettini M; Parise P; Ricotta S; Iorio A; Peirone C; Nenci GG
Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396
[TBL] [Abstract][Full Text] [Related]
12. To what extent are the effects of diet on coronary heart disease lipid-mediated?
Serrano-Martinez M; Martinez-Losa E; Prado-Santamaria M; Brugarolas-Brufau C; Fernandez-Jarne E; Martinez-Gonzalez MA
Int J Cardiol; 2004 May; 95(1):35-8. PubMed ID: 15159035
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of the lipid-protein spectrum of lipoproteins and fatty acid composition of lipids in plasma and erythrocytes of native populations of Chukotka and Moscow].
Gerasimova EN; Levachev MM; Ozerova IN; Polesskiĭ VA; Shcherbakova IA; Metel'skaia VA; Kulakova SN; Astakhova TI; Nikitin IuP; Perova NV
Vopr Med Khim; 1989; 35(5):7-11. PubMed ID: 2617942
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
[TBL] [Abstract][Full Text] [Related]
15. [The relationship of cholesterol (CHO) and triglycerides (TG) in VLDL, LDL, and VLDL subfractions by agarose gel electrophoresis, using CHO and TG dual staining (AG-CHO, TG staining)].
Miyake N; Iizuka K
Rinsho Byori; 2002 Jun; 50(6):605-12. PubMed ID: 12166081
[TBL] [Abstract][Full Text] [Related]
16. [Effects of anti-atherosclerosis diet containing omega 3 fatty acids on the lipid spectrum of blood and cell membranes in patients with ischemic heart disease and essential hypertension].
Samsonov MA; Levachev MM; Pogozheva AV; Korf II; Abbakumov AS; Feofilaktova SN; Dreval' AV
Vopr Pitan; 1990; (5):14-8. PubMed ID: 2275120
[TBL] [Abstract][Full Text] [Related]
17. Effects of two lipid-lowering, carotenoid-controlled diets on the oxidative modification of low-density lipoproteins in free-living humans.
Ahuja KD; Ashton EL; Ball MJ
Clin Sci (Lond); 2003 Sep; 105(3):355-61. PubMed ID: 12780345
[TBL] [Abstract][Full Text] [Related]
18. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
[TBL] [Abstract][Full Text] [Related]
19. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters.
Bryhn M; Hansteen H; Schanche T; Aakre SE
Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):19-24. PubMed ID: 16806871
[TBL] [Abstract][Full Text] [Related]
20. [Chances in the serum lipid values after conversion to a "reasonable" diet (author's transl)].
Mertz DP; Wobbe HD; Berger A; Göhmann E
Med Klin; 1977 Jan; 72(2):47-54. PubMed ID: 189169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
